Abstract:Alzheimer's disease (AD) is a neurodegenerative disease affecting mental ability and neurocognitive functions. Cholinesterase enzymes affect concentration of acetylcholine in the brain, leading to dementia. Thus, there is an urgent need to develop novel dual cholinesterase inhibitors as possible anti-AD drugs. Herein, we have designed and synthesized a novel series of 9 H -carbazole-4 H -chromenes 4 ( a-l ) through a one-pot three-component reaction of salicylaldehydes (1) , hydroxycarbazole (2) and N -methyl-1-(methylthio)-2-nitroethenamine (3) using triethylamine as a catalyst in ethanol. Synthetic transformation involves the formation of two C–C bonds and one C–O bond in a single step to obtain desired analogs. The rapid one-pot reaction does not require chromatographic purification, proceeds under mild conditions, and exhibits good tolerance toward various functional groups with high synthetic yields. Synthesized compounds were screened for cytotoxicity using MTT assay in BV-2 microglial cells. These compounds were then in-vitro screened against acetylcholinesterase (AChE) and butyrylcholinestrase (BuChE) enzymes. Most of these ligands have shown dual cholinesterase inhibitory activity compared to the standard drug. In-vitro results showed that the compounds 4a and 4d have promising anticholinesterase response against both cholinesterase enzymes ( 4a , AChE IC 50 : 5.76 μM, BuChE IC 50 : 48.98 μM; 4d , AChE IC 50 : 3.58 μM, BuChE IC 50 : 42.73 μM). In-vitro results were validated by molecular docking and dynamic simulation at 100 ns. Molecular docking and molecular dynamics simulation study strongly supported structural features present in these analogs. Together, these analogs could be exploited to develop dual anti-cholinesterase candidates to treat AD in combination with other drugs.

Design, synthesis, anti-acetylcholinesterase evaluation and molecular modelling studies of novel coumarin-chalcone hybrids

Benzyloxychalcone Hybrids as Prospective Acetylcholinesterase Inhibitors against Alzheimer's Disease: Rational Design, Synthesis, In Silico ADMET Prediction, QSAR, Molecular Docking, DFT, and Molecular Dynamic Simulation Studies

Novel chalcone derivatives of ursolic acid as acetylcholinesterase inhibitors: Synthesis, characterization, biological activity, ADME prediction, molecular docking and molecular dynamics studies

Structure–activity Relationship Investigation of Coumarin–chalcone Hybrids with Diverse Side-Chains As Acetylcholinesterase and Butyrylcholinesterase Inhibitors

Design, synthesis and docking study of novel coumarin ligands as potential selective acetylcholinesterase inhibitors

Design, Synthesis, and Acetylcholinesterase Inhibitory Activity of Novel Coumarin Analogues

Design, synthesis, and bio-evaluation of new isoindoline-1,3-dione derivatives as possible inhibitors of acetylcholinesterase

Design, Synthesis, Biological Evaluation, and Molecular Modeling Studies of Chalcone-Rivastigmine Hybrids As Cholinesterase Inhibitors

Synthesis of Flavonoid/Sulfonamide Hybrid Molecules as Potential Inhibitors of Cholinesterases: In Vitro, Molecular Docking, Molecular Dynamic and DFT Studies

Design, synthesis and biological evaluation of new carbazole-coumarin hybrids as dual binding site inhibitors of acetylcholinesterase

Design, synthesis, biological evaluation, and molecular dynamics of novel cholinesterase inhibitors as anti‐Alzheimer's agents

Design, Synthesis, Biological Evaluation, and Molecular Modeling Studies of Quinoline-Ferulic Acid Hybrids As Cholinesterase Inhibitors.

Development of novel 9H-carbazole-4H-chromene hybrids as dual cholinesterase inhibitors for the treatment of Alzheimer's disease

Acetylcholine Inhibitory Study of Novel Thio Linked Coumarin-Benzimidazole Derivatives: Design, Synthesis, Computational, and In Silico Molecular Docking Studies

Anticholinesterase activities of novel isoindolin-1,3-dione-based acetohydrazide derivatives: design, synthesis, biological evaluation, molecular dynamic study

Design, Synthesis and Pharmacological Evaluation of Chalcone Derivatives As Acetylcholinesterase Inhibitors

Design, Synthesis and Molecular Modeling of Isothiochromanone Derivatives As Acetylcholinesterase Inhibitors

Development of promising acetylcholinesterase and butyrylcholinesterase inhibitors: Synthesis, in vitro and in silico approaches of pyridine derived fused bis-oxadiazole and bis-thiadiazole derivatives

Design, Synthesis and Evaluation of Novel Tacrine Coumarin Hybrids As Multifunctional Cholinesterase Inhibitors Against Alzheimer'S Disease

Synthesis, computational docking and molecular dynamics studies of a new class of spiroquinoxalinopyrrolidine embedded chromanone hybrids as potent anti-cholinesterase agents

Design, Synthesis, Biological Evaluation and Docking Study of 4-Isochromanone Hybrids Bearing N-benzyl Pyridinium Moiety As Dual Binding Site Acetylcholinesterase Inhibitors